Vicarious Surgical (RBOT) Form 144: Insider Sale Notice for 817 Shares

Rhea-AI Filing Summary

Form 144 notice for Vicarious Surgical Inc. (RBOT) reports a proposed sale of Class A common stock through UBS Financial Services. The filing shows 817 shares proposed for sale with an aggregate market value of $5,212.46 and lists the approximate sale date as 08/20/2025 on the NYSE. The securities were acquired by the reporting person on 08/19/2025 as a restricted stock lapse, with 2,378 shares noted as acquired on that date. The filing also discloses three sales by the same seller in the past three months: 817 shares on 05/20/2025 for $5,961, 463 shares on 06/03/2025 for $3,210, and 279 shares on 06/23/2025 for $2,067. The notice includes the seller’s signed representation that they are not aware of any undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Routine Rule 144 sale notice showing small open-market disposals following a restricted stock lapse.

The filing documents a proposed sale of 817 Class A shares via UBS with stated market value of $5,212.46 and lists prior small sales in May and June 2025. The shares were recorded as acquired on 08/19/2025 by restricted stock lapse, indicating these securities recently became eligible for sale under Rule 144. The report is procedural and contains the standard representation that the seller does not possess undisclosed material information.

Corporate Governance Expert

TL;DR: Insider disposition disclosed under Rule 144; filing follows required attestation language and broker details.

The notice provides necessary broker identification (UBS Financial Services) and seller contact, and discloses the acquisition mechanism as a restricted stock lapse. It includes the statutory attestation about absence of undisclosed material adverse information, which is customary. The disclosure appears complete for a Rule 144 notice and raises no immediate procedural governance flags within the content provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	817	5212.46	5298253	08/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	08/19/2025	Restricted Stock Lapse	Vicarious Surgical Inc.			2378	08/19/2025	Restricted Stock Lapse

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam Sachs 78 4th Ave Waltham MA 02451	Class A Common Stock	05/20/2025	817	5961
Adam Sachs 78 4th Ave Waltham MA 02451	Class A Common Stock	06/03/2025	463	3210
Adam Sachs 78 4th Ave Waltham MA 02451	Class A Common Stock	06/23/2025	279	2067

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for RBOT report?

The Form 144 reports a proposed sale of 817 Class A common shares of Vicarious Surgical Inc. through UBS Financial Services with aggregate market value $5,212.46 and approximate sale date 08/20/2025.

When were the securities being sold acquired according to the filing?

The filing states the securities were acquired on 08/19/2025 via a restricted stock lapse, with 2,378 shares noted as acquired on that date.

Has the filer sold other RBOT shares recently?

Yes. The filing lists sales in the past three months: 817 shares on 05/20/2025 for $5,961, 463 shares on 06/03/2025 for $3,210, and 279 shares on 06/23/2025 for $2,067.

Which broker is handling the proposed sale?

The proposed sale is listed as handled by UBS Financial Services Inc, 1000 Harbor Blvd, Weehawken, NJ.

Does the filer assert possession of any undisclosed material information?

No. The seller signs the notice representing they do not know of any material adverse information about the issuer that has not been publicly disclosed.